PMV 파머슈티컬스(PMVP)는 NAS에 상장된 Healthcare · Biotechnology 기업입니다. 현재가 $1.50 (+2.74%), 시가총액 $68.80M, 52주 범위 $0.87 ~ $1.80.
PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule therapies targeting p53 mutations and other p53-related cancers in the United States. It develops rezatapopt, a selective structural corrector of p53 Y220C mutations in Phase 2 clinical trials for tumor agnostic diseases. The company was formerly known as PJ Pharmaceuticals, Inc. and changed its name to PMV Pharmaceuticals, Inc. in July 2013. PMV Pharmaceuticals, Inc. was incorporated in 2013 and is headquartered in Princeton, New Jersey.
PMV 파머슈티컬스의 재무제표, 목표주가, 기관투자자(13F) 보유 현황, 관련 뉴스는 XTS에서 실시간으로 확인할 수 있습니다.
PMV 파머슈티컬스의 현재 주가는 $1.50 (+2.74%)입니다. XTS에서 실시간 시세와 차트를 확인할 수 있습니다.
PMV 파머슈티컬스의 시가총액은 약 $68.80M입니다.
PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule therapies targeting p53 mutations and other p53-related cancers in the United…